Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Galli · SciRah

Researcher profile · Semantic Scholar

C. Galli

Share profile

C. Galli — researcher profile on SciRah

h-index: 8
Works: 23
Citations: 464

Most-cited papers

Hypersensitivity reactions related to oxaliplatin (OHP)
Giovanni Brandi, M. Pantaleo, C. Galli, A. Falcone +4 more
2003British Journal of Cancer137 citations Open access
Semantic Scholar
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
A. Fontana, L. Galli, A. Fioravanti, P. Orlandi +12 more
2009Clinical Cancer Research89 citations Open access
Semantic Scholar
Sorafenib plus daily low dose temozolomide for relapsed glioblastoma: A phase II study.
F. Zustovich, L. Landi, G. Lombardi, L. Galli +7 more
2011Journal of Clinical Oncology82 citations
Semantic Scholar
Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study
S. Chibbaro, L. Benvenuti, A. Caprio, S. Carnesecchi +7 more
2004Journal of Neuro-Oncology42 citations
Semantic Scholar
Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques.
Paola Loli, F. Vignati, E. Grossrubatscher, P. Dalino +9 more
2003Journal of Clinical Endocrinology and Metabolism31 citations Open access
Semantic Scholar
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
F. di Costanzo, A. Sobrero, S. Gasperoni, L. Dogliotti +17 more
2003Annals of Oncology29 citations Open access
Semantic Scholar
Suramin in Combination with 5-Fluorouracil (5-FU) and Leucovorin (LV) in Metastatic Colorectal Cancer Patients Resistant to 5-FU+LV-Based Chemotherapy
A. Falcone, Elisabetta Pfanner, I. Brunetti, Giacomo Ailegrini +7 more
1998Tumori19 citations Open access
Semantic Scholar
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
A. Falcone, G. Allegrini, M. Lencioni, Elisabetta Pfanner +6 more
1999Cancer Chemotherapy and Pharmacology16 citations Open access
Semantic Scholar
Invasive candidiasis does not complicate short-term cimetidine treatment of duodenal ulcer.
G. Minoli, V. Terruzzi, G. Butti, A. Prada +5 more
1987Gastrointestinal Endoscopy7 citations
Semantic Scholar
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.
F. Zustovich, L. Landi, Giuseppe Lombardi, Camillo Porta +7 more
2013Anticancer Research4 citations
Semantic Scholar
Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer
L. Galli, A. Fontana, C. Galli, L. Landi +7 more
2007British Journal of Cancer4 citations Open access
Semantic Scholar
5-Fluorouracil Administered as a 48-Hour Semiintermittent Infusion in Combination With Leucovorin, Cisplatin and Epirubicin: Phase II Study in Advanced Gastric Cancer Patients
G. Allegrini, A. Falcone, R. Di Marsico, M. Lencioni +6 more
2004American Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination
A. Fontana, G. Bocci, L. Galli, E. Fontana +16 more
20061 citations
Semantic Scholar
A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed
G. Masi, A. di Paolo, G. Allegrini, S. Cupini +5 more
20011 citations
Semantic Scholar
Cancer Therapy : Clinical Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide , Celecoxib , and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
A. Fontana, L. Galli, A. Fioravanti, P. Orlandi +12 more
20090 citations
Semantic Scholar
Metronomic oral vinorelbine (V) and dexamethasone (D) in patients with advanced castration resistant prostate cancer (CRPC): a phase II clinical study with pharmacokinetic (PK) and pharmacodynamic (PD) evaluations
L. Galli, A. Fontana, L. Derosa, G. Minuti +10 more
20090 citations
Semantic Scholar
Docetaxel-prednisone (DP) plus metronomic cyclophosphamide (CTX) and celecoxib (C) as first line treatment in castration resistant prostate cancer (CRPC): phase II trial with pharmacodynamic evaluation
A. Fontana, L. Galli, L. Derosa, G. Minuti +12 more
20090 citations
Semantic Scholar
Phase II clinical trial with pharmacodynamic evaluation of docetaxel/prednisone plus metronomic cyclophosphamide and celecoxib as first line treatment in metastatic hormone refractory prostate cancer (MHRPC)
A. Fontana, G. Bocci, M. D'Arcangelo, L. Galli +13 more
20080 citations
Semantic Scholar
Retrospective analysis of concomitant treatment with 3-dimensional conformal radiotherapy and temozolomide in high-grade glioma patients
L. Landi, A. Fontana, C. Galli, L. Galli +10 more
20080 citations
Semantic Scholar
Docetaxel (D) plus prednisone (P) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) as first line chemotherapy in metastatic hormone refractory prostate cancer (HRPC): Phase II clinical trial with pharmacodynamic evaluation
A. Fontana, G. Bocci, M. D'Arcangelo, L. Galli +6 more
20080 citations
Semantic Scholar
4029 POSTER Phase II clinical trial of metronomic cyclophosphamide (CTX) plus celecoxib (C) and dexamethasone (DEX) in advanced hormone refractory prostate cancer (HRPC): preliminary clinical and pharmacodynamic results
A. Fontana, G. Bocci, M. D'Arcangelo, L. Galli +11 more
20070 citations
Semantic Scholar
A phase II pilot study of sequential chemo-immunotherapy with capecitabina+ interferon α2A (IFN) followed by interleukina-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC): on behalf of the Gruppo Oncologico Nord Ovest (G.O.N.O.)
E. Fontana, A. Fontana, C. Galli, L. Galli +13 more
20060 citations
Semantic Scholar
582 A phase I study of day 1 and 8 every three weeks docetaxel infusion
P. Giannessi, R. Di Marsico, F. Martella, C. Galli +4 more
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Falcone×16
Invite
A. Falcone — researcher profile on SciRah
A. Antonuzzo×13
Invite
A. Antonuzzo — researcher profile on SciRah
L. Landi×13
Invite
L. Landi — researcher profile on SciRah
M. Andreuccetti×10
Invite
M. Andreuccetti — researcher profile on SciRah

×8

Invite

L. Galli — researcher profile on SciRah

Invite

E. Fontana — researcher profile on SciRah

R. Di Marsico×8

Invite

R. Di Marsico — researcher profile on SciRah

M. del Tacca×8

Invite

M. del Tacca — researcher profile on SciRah

Invite

G. Bocci — researcher profile on SciRah

Invite

A. Fontana — researcher profile on SciRah

Invite

S. Bursi — researcher profile on SciRah

G. Allegrini×6

Invite

G. Allegrini — researcher profile on SciRah